121 related articles for article (PubMed ID: 9089801)
21. Simultaneous determination of leukotrienes B4 and E4 in whole blood and of leukotriene E4 in urine of rabbit by reversed-phase high-performance liquid chromatography.
Celardo A; Dell'Elba G; Eltantawy ZM; Evangelista V; Cerletti C
J Chromatogr B Biomed Appl; 1994 Aug; 658(2):261-9. PubMed ID: 7820254
[TBL] [Abstract][Full Text] [Related]
22. Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders.
Micheletto C; Visconti M; Tognella S; Trevisan F; Dal Negro RW
Eur Ann Allergy Clin Immunol; 2007 May; 39(5):162-6. PubMed ID: 17626331
[TBL] [Abstract][Full Text] [Related]
23. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist.
Reiss TF; Hill JB; Harman E; Zhang J; Tanaka WK; Bronsky E; Guerreiro D; Hendeles L
Thorax; 1997 Dec; 52(12):1030-5. PubMed ID: 9516894
[TBL] [Abstract][Full Text] [Related]
24. Early increase in urinary leukotriene E4 (LTE4) is dependent on allergen dose inhaled during bronchial challenge in asthmatic subjects.
Bancalari L; Conti I; Giannessi D; Lazzerini G; Dente FL; De Caterina R; Paggiaro PL
Allergy; 1999 Dec; 54(12):1278-85. PubMed ID: 10688431
[TBL] [Abstract][Full Text] [Related]
25. Serum leukotriene B4 levels in patients with obstructive pulmonary disease.
Seggev JS; Thornton WH; Edes TE
Chest; 1991 Feb; 99(2):289-91. PubMed ID: 1846571
[TBL] [Abstract][Full Text] [Related]
26. Simplified method for measuring urinary leukotriene E4.
Qiu DW; Hui KP; Lee CW; Lim TK; Tan WC
J Chromatogr B Biomed Appl; 1996 Feb; 677(1):152-5. PubMed ID: 8925088
[TBL] [Abstract][Full Text] [Related]
27. Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD.
Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
Pulm Pharmacol Ther; 2014 Aug; 28(2):158-64. PubMed ID: 24076367
[TBL] [Abstract][Full Text] [Related]
28. Airway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects.
Christie PE; Schmitz-Schumann M; Spur BW; Lee TH
Eur Respir J; 1993 Nov; 6(10):1468-73. PubMed ID: 8112440
[TBL] [Abstract][Full Text] [Related]
29. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.
Higashi N; Taniguchi M; Mita H; Kawagishi Y; Ishii T; Higashi A; Osame M; Akiyama K
J Allergy Clin Immunol; 2004 Feb; 113(2):277-83. PubMed ID: 14767442
[TBL] [Abstract][Full Text] [Related]
30. The effect of oral corticosteroids on bronchodilator responses in COPD.
Corden Z; Rees PJ
Respir Med; 1998 Feb; 92(2):279-82. PubMed ID: 9616526
[TBL] [Abstract][Full Text] [Related]
31. The preflight evaluation. A comparison of the hypoxia inhalation test with hypobaric exposure.
Dillard TA; Moores LK; Bilello KL; Phillips YY
Chest; 1995 Feb; 107(2):352-7. PubMed ID: 7842760
[TBL] [Abstract][Full Text] [Related]
32. Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma.
Yamaguchi T; Ishii T; Yamamoto K; Higashi N; Taniguchi M; Okamoto M
Auris Nasus Larynx; 2016 Jun; 43(3):304-8. PubMed ID: 26527517
[TBL] [Abstract][Full Text] [Related]
33. Erdosteine affects eicosanoid production in COPD.
Dal Negro RW; Visconti M; Tognella S; Micheletto C
Int J Clin Pharmacol Ther; 2011 Jan; 49(1):41-5. PubMed ID: 21176724
[TBL] [Abstract][Full Text] [Related]
34. Atopic children with cystic fibrosis have increased urinary leukotriene E4 concentrations and more severe pulmonary disease.
Greally P; Cook AJ; Sampson AP; Coleman R; Chambers S; Piper PJ; Price JF
J Allergy Clin Immunol; 1994 Jan; 93(1 Pt 1):100-7. PubMed ID: 8308175
[TBL] [Abstract][Full Text] [Related]
35. Urinary leukotriene E4.
Rabinovitch N
Immunol Allergy Clin North Am; 2007 Nov; 27(4):651-64; vii. PubMed ID: 17996582
[TBL] [Abstract][Full Text] [Related]
36. Impact of hypoxaemia on neuroendocrine function and catecholamine secretion in chronic obstructive pulmonary disease (COPD). Effects of long-term oxygen treatment.
Bratel T; Wennlund A; Carlström K
Respir Med; 2000 Dec; 94(12):1221-8. PubMed ID: 11192959
[TBL] [Abstract][Full Text] [Related]
37. Critical considerations in the development of an assay for sulfidopeptide leukotrienes in plasma.
Heavey DJ; Soberman RJ; Lewis RA; Spur B; Austen KF
Prostaglandins; 1987 May; 33(5):693-708. PubMed ID: 3035620
[TBL] [Abstract][Full Text] [Related]
38. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis.
Taylor GW; Taylor I; Black P; Maltby NH; Turner N; Fuller RW; Dollery CT
Lancet; 1989 Mar; 1(8638):584-8. PubMed ID: 2564113
[TBL] [Abstract][Full Text] [Related]
39. Familial factors affecting arterial blood gas values and respiratory chemosensitivity in chronic obstructive pulmonary disease.
Kawakami Y; Irie T; Shida A; Yoshikawa T
Am Rev Respir Dis; 1982 Apr; 125(4):420-5. PubMed ID: 6803634
[TBL] [Abstract][Full Text] [Related]
40. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM
Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
